Law360, New York (July 02, 2009) -- A federal judge has allowed for expanded discovery and has refused Actavis Group's bid to quash a subpoena in the multidistrict product liability case accusing Actavis of selling a defective or adulterated heart medication.
Judge Mary E. Stanley's pretrial discovery ruling, issued Wednesday in the U.S. District Court for the Southern District of West Virginia, stopped short of allowing the plaintiffs to investigate all...
